Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Strahm

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|February 7, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppressionBarbara Meissner, Peter Lang, Peter Bader, et al.
Blood|January 13, 2012
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMMLShinsuke Hirabayashi, Christian Flotho, Jessica Moetter, et al.
Blood|March 17, 2011
Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcomeChristiane Olk-Batz, Anna R Poetsch, Peter Nöllke, et al.
British Journal of Haematology|January 15, 2016
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study groupAnnamaria M Cseh, Charlotte M Niemeyer, Ayami Yoshimi, et al.
Haematologica|May 19, 2018
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB studyNatasha K A van Eijkelenburg, Mareike Rasche, Essam Ghazaly, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Blood|August 31, 2010
Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndromeGudrun Göhring, Kyra Michalova, H Berna Beverloo, et al.
British Journal of Haematology|December 2, 2017
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trialMichaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Blood Advances|April 29, 2020
Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemiaBrigitte Strahm, Felicia Loewecke, Charlotte M Niemeyer, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|February 7, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppressionBarbara Meissner, Peter Lang, Peter Bader, et al.
Blood|January 13, 2012
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMMLShinsuke Hirabayashi, Christian Flotho, Jessica Moetter, et al.
Blood|March 17, 2011
Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcomeChristiane Olk-Batz, Anna R Poetsch, Peter Nöllke, et al.
British Journal of Haematology|January 15, 2016
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study groupAnnamaria M Cseh, Charlotte M Niemeyer, Ayami Yoshimi, et al.
Haematologica|May 19, 2018
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB studyNatasha K A van Eijkelenburg, Mareike Rasche, Essam Ghazaly, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Blood|August 31, 2010
Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndromeGudrun Göhring, Kyra Michalova, H Berna Beverloo, et al.
British Journal of Haematology|December 2, 2017
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trialMichaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Blood Advances|April 29, 2020
Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemiaBrigitte Strahm, Felicia Loewecke, Charlotte M Niemeyer, et al.
Pageof 10